Pneumolysin-induced complement depletion during experimental pneumococcal bacteremia

被引:33
作者
Alcantara, RB
Preheim, LC
Gentry-Nielsen, MJ
机构
[1] Vet Affairs Med Ctr, Res Serv 151, Omaha, NE 68105 USA
[2] Creighton Univ, Sch Med, Omaha, NE 68178 USA
[3] Univ Nebraska, Coll Med, Omaha, NE 68182 USA
关键词
D O I
10.1128/IAI.69.6.3569-3575.2001
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
To quantify complement depletion by pneumolysin during Streptococcus pneumoniae bacteremia, cirrhotic and control rats were infected intravenously with one of three isogenic mutant strains of S. pneumoniae expressing different forms of pneumolysin. Outcome measures included clearance of the organisms from the bloodstream, alterations in 50% serum hemolytic complement (CH50) activity and complement C3 levels during infection, and serum opsonic capacity at 18 h postinfection. Cirrhotic rats had significantly lower CH50 and C3 levels than control rats, both before and after infection, However, initial complement levels did not predict bacterial load after 18 h of infection, Changes in CH50 and C3 levels over the 18-h period correlated with numbers of H+C+ but not H+C- or PLY- organisms in the bloodstream at 18 h postinfection, The sera of cirrhotic rats infected with the H+C+ strain had significantly decreased levels of C3 and showed significantly lower opsonizing activity for S. pneumoniae than sera from H+C+-infected control rats. These studies suggest that under limiting concentrations of complement, the expression of pneumolysin by pneumococci has a significant, negative effect on serum complement levels and reduces serum opsonic activity.
引用
收藏
页码:3569 / 3575
页数:7
相关论文
共 32 条
[1]   INFECTIONS IN THE ALCOHOLIC [J].
ADAMS, HG ;
JORDAN, C .
MEDICAL CLINICS OF NORTH AMERICA, 1984, 68 (01) :179-200
[2]   Role of pneumolysin's complement-activating activity during pneumococcal bacteremia in cirrhotic rats [J].
Alcantara, RB ;
Preheim, LC ;
Gentry, MJ .
INFECTION AND IMMUNITY, 1999, 67 (06) :2862-2866
[3]   The hemolytic and complement-activating properties of pneumolysin do not contribute individually to virulence in a pneumococcal bacteremia model [J].
Benton, KA ;
Paton, JC ;
Briles, DE .
MICROBIAL PATHOGENESIS, 1997, 23 (04) :201-209
[4]   LOCALIZATION OF COMPLEMENT COMPONENT-3 ON STREPTOCOCCUS-PNEUMONIAE - ANTI-CAPSULAR ANTIBODY CAUSES COMPLEMENT DEPOSITION ON THE PNEUMOCOCCAL CAPSULE [J].
BROWN, EJ ;
JOINER, KA ;
COLE, RM ;
BERGER, M .
INFECTION AND IMMUNITY, 1983, 39 (01) :403-409
[5]  
BROWN EJ, 1983, REV INFECT DIS, V5, pS797
[6]  
BROWN EJ, 1983, INFECT IMMUN, V5, pS797
[7]   MECHANISMS OF HOST DEFENSE AGAINST INFECTION WITH STREPTOCOCCUS-PNEUMONIAE [J].
BRUYN, GAW ;
ZEGERS, BJM ;
VANFURTH, R .
CLINICAL INFECTIOUS DISEASES, 1992, 14 (01) :251-262
[8]  
DEE TH, 1977, J LAB CLIN MED, V89, P1198
[9]   PHAGOCYTOSIS OF STREPTOCOCCUS-PNEUMONIAE MEASURED IN-VITRO AND IN-VIVO IN A RAT MODEL OF CARBON TETRACHLORIDE-INDUCED LIVER-CIRRHOSIS [J].
GENTRY, MJ ;
SNITILY, MU ;
PREHEIM, LC .
JOURNAL OF INFECTIOUS DISEASES, 1995, 171 (02) :350-355
[10]   THE ROLE OF OPSONINS IN RECOVERY FROM EXPERIMENTAL PNEUMOCOCCAL PNEUMONIA [J].
GUCKIAN, JC ;
CHRISTENSEN, GD ;
FINE, DP .
JOURNAL OF INFECTIOUS DISEASES, 1980, 142 (02) :175-190